Can 3D Ultrasound Be Used Reproducibly by Radiation Therapists in Partial Breast Image-Guided Radiation Therapy
NCT ID: NCT00911456
Last Updated: 2012-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
27 participants
INTERVENTIONAL
2009-10-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy
NCT01537406
Automated Breast Radiation Therapy Using an MR-Guided Process
NCT01999062
Assessment of Substitution of Focused Cliches and Ultrasound for Tomosynthesis
NCT01612650
3D Breast Ultrasound Elastography in Patients Under Neoadjuvant Chemotherapy
NCT01531036
Concurrent Boost Radiotherapy
NCT00981864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
IGRT Assessment The patient will be set up on the breast board in treatment position. The 'ultra path' component of the Clarity system, which displays the path of the previous US acquired at CT simulation, will be used to guide the acquisition of US2. Although performed in the simulator room, the Clarity system will be used in 'treatment mode' thus simulating Clarity as it is used for IGRT. The study RT will first acquire the US2 scan. All steps following the acquisition of US2 will be performed off-line on the RM workstation without the need for further simulator or patient time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Image-Guided Radiation Therapy using 3D Ultrasound Guided-Therapy
Subjects will have 3 x 3DUS during radiation therapy
Ultrasound Guided Imaging
Subjects will undergo a CT scan and an US of your breast for the planning of radiation therapy after a breast conserving operation.
About 1 week after the start of radiation treatment subjects will have a second CT and US. During this visit subjects will have one CT and three US's. These US's will be performed by 3 different radiation therapists. Part of the current study is to compare the similarity of the 3 US pictures taken by different individuals.
3 DUS
3 DUS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women must have primary tumors \<3cm, pathologically N0 disease, and negative surgical margins.
* Seroma clarity score \<2
Exclusion Criteria
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Columbia Cancer Agency
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
British Columbia Cancer Agency
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tanya Berrang
Role: PRINCIPAL_INVESTIGATOR
British Columbia Cancer Agency
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BC Cancer Agency Vancouver Island BCCA
Victoria, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.